PharmaCorp Rx Inc. (TSXV:PCRX)
Canada flag Canada · Delayed Price · Currency is CAD
0.430
-0.020 (-4.44%)
Apr 29, 2026, 2:20 PM EST

PharmaCorp Rx Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Apr '26 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
7563412-
Market Cap Growth
18.59%1387.38%-64.51%--
Enterprise Value
753829-
Last Close Price
0.450.540.210.60-
PS Ratio
4.2710.93---
PB Ratio
2.492.071.874.42-
P/TBV Ratio
9.394.611.874.42-
P/FCF Ratio
48.80536.42---
P/OCF Ratio
46.73506.85---
EV/Sales Ratio
4.246.54---
EV/FCF Ratio
48.49321.02---
Debt / Equity Ratio
0.140.03---
Debt / FCF Ratio
2.818.07---
Net Debt / Equity Ratio
-0.02-0.39-0.99-1.01-1.01
Net Debt / EBITDA Ratio
-1.658.86---
Net Debt / FCF Ratio
-0.46-101.064.3222.74-622.24
Asset Turnover
0.490.31---
Quick Ratio
1.747.7948.54166.0137.20
Current Ratio
2.538.5950.24166.0137.98
Return on Equity (ROE)
0.61%-6.40%-18.85%-28.02%-
Return on Assets (ROA)
-0.42%-5.29%-14.29%-18.85%-
Return on Capital Employed (ROCE)
-0.70%-4.70%-25.40%-20.70%-8.20%
Earnings Yield
0.25%-1.60%-11.05%-4.31%-
FCF Yield
2.05%0.19%-12.20%-1.00%-
Buyback Yield / Dilution
-0.34%-303.02%-1.39%-23.69%-
Source: S&P Capital IQ. Standard template. Financial Sources.